667 LP
- Assets, Funds, Holdings
| Form 3/4/5 Subject |
2011 - 2025 |
|
Kodiak Sciences Inc.
|
|
|
Baker Brothers Life Sciences LP
|
|
|
Baker Bros. Advisors (GP) LLC
|
|
|
667 LP
|
|
|
Baker Julian
|
|
|
Baker Felix
|
|
|
Baker Bros Advisors LP
|
|
|
Incyte Corp
|
|
|
vTv Therapeutics Inc.
|
|
|
Kymera Therapeutics, Inc.
|
|
|
Madrigal Pharmaceuticals Inc
|
|
|
BeOne Medicines Ltd.
|
|
|
Prelude Therapeutics Inc
|
|
|
Denali Therapeutics Inc.
|
|
|
Acadia Pharmaceuticals Inc
|
|
|
Kiniksa Pharmaceuticals International, plc
|
|
|
TScan Therapeutics, Inc.
|
|
|
Replimune Group, Inc.
|
|
|
DBV Technologies S.A.
|
|
|
Bicycle Therapeutics PLC
|
|
|
IGM Biosciences, Inc.
|
|
|
Immunocore Holdings plc
|
|
|
Neurogene Inc.
|
|
|
Seagen Inc.
|
|
|
Talis Biomedical Corp
|
|
|
Spyre Therapeutics, Inc.
|
|
|
Alexion Pharmaceuticals Inc
|
|
|
Zymeworks Inc.
|
|
|
Baker Bros. Investments, L.P.
|
|
|
Baker/Tisch Investments, LP
|
|
|
14159 LP
|
|
|
Genomic Health Inc
|
|
|
Baker Bros. Investments II, L.P.
|
|
|
Aceragen, Inc.
|
|
|
XOMA Royalty Corp
|
|
|
Synageva Biopharma Corp
|
|
|
Baker Biotech Fund II (A), L.P.
|
|
|
Mirati Therapeutics, Inc.
|
|
|
Biocryst Pharmaceuticals Inc
|
|
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "update_card": "/update-card"}
{"uid": 210584076, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
313065719